Alzamend Neuro Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year Ending	Current	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Capitalization	3	53	92	-
Market Cap Growth	-90.43%	-42.57%	-	-
Enterprise Value	3	48	78	-2
PE Ratio	-	-3.55	-7.43	-
PB Ratio	-1.44	17.33	6.88	-
P/FCF Ratio	-0.66	-5.92	-13.68	-
P/OCF Ratio	-0.67	-5.92	-13.90	-
EV/EBITDA Ratio	-0.47	-3.21	-6.32	0.33
EV/EBIT Ratio	-0.47	-3.20	-6.32	0.33
EV/FCF Ratio	-0.63	-5.34	-11.58	0.59
Debt / Equity Ratio	-	-	-	0.17
Debt / EBITDA Ratio	-	-	-	-0.07
Debt / FCF Ratio	-	-	-	-0.12
Quick Ratio	0.07	1.79	12.07	2.14
Current Ratio	0.16	2.03	12.37	3.24
Interest Coverage	-1353.94	-1930.98	-264.71	-30.78
Return on Equity (ROE)	1235.90%	-206.10%	-92.10%	-356.10%
Return on Assets (ROA)	-481.20%	-160.60%	-84.90%	-213.50%
Return on Capital (ROIC)	290.65%	-488.28%	-92.27%	-210.88%
Earnings Yield	-417.68%	-28.19%	-13.45%	-
FCF Yield	-310.71%	-16.91%	-7.31%	-
Buyback Yield / Dilution	-7.62%	-9.45%	-22.64%	-1.96%
Total Shareholder Return	-7.62%	-9.45%	-22.64%	-1.96%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).